2015-2019 Global Mycoplasma Diagnostic Testing Market: Emerging Opportunities and Growth Strategies
The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
Contains 202 pages and 15 tables
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices- Public Health Labs
Contains 202 pages and 15 tables
I. INTRODUCTION
II. MYCOPLASMA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
II. MYCOPLASMA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
Major Companies Developing or Marketing Mycoplasma Tests
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Italy Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Mycoplasma Tests
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Italy Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
More Publications
2013 UK Transfusion Diagnostic Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
December 2012
422 pages
2013 US Transfusion Diagnostic Testing Market; Opportunities and Strategies for Suppliers
US$ 7,120.00
December 2012
460 pages
2015-2019 Europe Immunodiagnostics Market: Emerging Opportunities for Instrument and Reagent Suppliers - Competitive Strategies, Supplier Shares, Country Volume and Sales Segment Forecasts for 100 Tests
US$ 15,760.00
July 2015
900 pages
2015-2019 Emerging Opportunities in the Mycoplasma Diagnostic Testing Market
US$ 3,480.00
July 2015
202 pages
2015-2019 Global Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
US$ 15,600.00
September 2015
775 pages